Temporal Changes in Secondary Prevention and Cardiovascular Outcomes after Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study

In patients undergoing revascularisation for peripheral arterial disease, use of antithrombotics and statins increased over time, and this was accompanied by a decline in the rate of a number of cardiovascular adverse events and all-cause mortality, but not major amputations.

Source:

Circulation